October 30, 2025, 5:15 PM - 6:15 PM CT
DLL3-Targeting Bispecific Antibodies for Small Cell Lung Cancer – From Innovation to Practice
This program brings together expert faculty to discuss the latest advances and enable the integration of these novel DLL3-targeted agents into ES-SCLC care. Through interactive, case-based discussions with a community oncology colleague, participants will gain practical insights and strategies to navigate emerging efficacy data, anticipate and manage therapy-related toxicities, and address the evolving challenges of patient care in this setting.
November 6, 2025, 5:15 PM - 6:15 PM CT
Optimizing SCLC Treatment Strategies and Managing Adverse Events Across Disease Stages
This Community Oncology Connections™ program is a series of live, online meetings focused on providing community oncologists with the latest updates to the management of SCLC, offering participants an opportunity to participate in discussion of novel approaches to maintenance therapy, immunotherapy, and the emerging role of novel targeted therapies across the treatment landscape.
Your professional development is important to us! Please check back for upcoming event listings or click the button below to sign up for email updates about upcoming meetings and educational opportunities.
If you are employed by a pharmaceutical/device manufacturer, consulting, or technology company, please contact CorporateRelations@accc-cancer.org.